Status:
COMPLETED
Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation
Lead Sponsor:
Mayo Clinic
Conditions:
Allergy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.
Detailed Description
This study will be a prospective study to accurately determine the negative predictive value of skin testing with NMBAs. It is hypothesized that the concentrations that should be used for NMBAs are a...
Eligibility Criteria
Inclusion
- All adults \> or = to 18 y/o undergoing surgery
Exclusion
- Minors under the age of 18 y/o, Adults unable to consent, or those Adults with previous allergic reaction history during previous surgeries.
Key Trial Info
Start Date :
September 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT04046731
Start Date
September 20 2019
End Date
December 31 2021
Last Update
February 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Jacksonville, Florida, United States, 32224